PQ-10

CAS No. 927691-21-2

PQ-10 ( PQ 10; PQ10; A844337; A-844337; A 844337 )

Catalog No. M27785 CAS No. 927691-21-2

PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 Get Quote
5MG 72 Get Quote
10MG 115 Get Quote
25MG 260 Get Quote
50MG 410 Get Quote
100MG 605 Get Quote
500MG 1287 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PQ-10
  • Note
    Research use only, not for human use.
  • Brief Description
    PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.
  • Description
    PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.(In Vivo):In mice, PQ-10 shows a region-specific increase in 2-DG uptake in the globus pallidus (equivalent to the outer part of the primate pallidus) and lateral habenula .
  • Synonyms
    PQ 10; PQ10; A844337; A-844337; A 844337
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    927691-21-2
  • Formula Weight
    403.4
  • Molecular Formula
    C22H21N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2ncnc(N3CCC(C3)Oc3cnc4ccccc4n3)c2cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lu Shi, et al. A Potential Anti-cancer Compound Separated from the Chloroform Extract of the Chinese Medicine Formula Shenqi San. Curr Med Sci. 2020 Feb;40(1):138-144.
molnova catalog
related products
  • ICI 63197

    ICI 63197 is a PDE4 inhibitor.

  • Enpp-1-IN-14

    ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.

  • BRL 50481

    BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.